Ensign Peak Advisors Inc raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 160.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 105,490 shares of the company's stock after buying an additional 65,014 shares during the period. Ensign Peak Advisors Inc's holdings in Ryan Specialty were worth $6,768,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mariner LLC grew its position in shares of Ryan Specialty by 3.4% in the 4th quarter. Mariner LLC now owns 5,278 shares of the company's stock valued at $339,000 after buying an additional 172 shares during the last quarter. Sanctuary Advisors LLC grew its holdings in shares of Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after purchasing an additional 188 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock worth $778,000 after purchasing an additional 190 shares during the last quarter. CIBC Asset Management Inc increased its position in shares of Ryan Specialty by 5.6% during the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock worth $236,000 after purchasing an additional 196 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its holdings in shares of Ryan Specialty by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock valued at $2,887,000 after purchasing an additional 280 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.
Insider Buying and Selling
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by company insiders.
Ryan Specialty Price Performance
Shares of Ryan Specialty stock traded down $0.65 during trading on Monday, hitting $70.06. 71,383 shares of the company were exchanged, compared to its average volume of 977,959. The firm has a 50 day moving average price of $70.16 and a 200 day moving average price of $68.75. The stock has a market capitalization of $18.38 billion, a price-to-earnings ratio of 101.50, a P/E/G ratio of 1.19 and a beta of 0.68. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a fifty-two week low of $52.34 and a fifty-two week high of $77.16.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. During the same quarter last year, the company earned $0.35 earnings per share. The business's revenue for the quarter was up 25.0% compared to the same quarter last year. On average, equities analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.
Ryan Specialty Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, May 13th. Ryan Specialty's payout ratio is 141.18%.
Analyst Upgrades and Downgrades
RYAN has been the topic of several research analyst reports. Royal Bank of Canada cut their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. TD Cowen assumed coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective on the stock. UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Keefe, Bruyette & Woods decreased their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Finally, Wells Fargo & Company reduced their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $76.42.
Get Our Latest Stock Report on RYAN
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.